Maroy B
Maison Médicale de Lunesse, Isle d'Espagnac.
Presse Med. 1997 Oct 25;26(32):1520-2.
Desmoid tumors are the second leading cause of mortality in patients with familial adenomatous polyposis who have undergone proctocolemy. Both medical and surgical treatment of these non-metastasizing but locally aggressive tumors are difficult.
A 20-years-old woman consulted 6 years after coloproctectomy for familial adenomatous polyposis. A mesenteric desmoid tumor was found. Resection was not possible. The tumor progressed under sulindac treatment and subocclusion developed. The patient was given tamoxifen, 20 mg/d and the size of the tumor began to regress within a few days together with pain and signs of compression. The treatment was well tolerated for 4.5 years and tumor volume has remained unchanged after a 20-fold reduction compared with the size prior to treatment. The patient has remained symptom-free.
In this critical clinical situation, tamoxifen provided rapid and prolonged effect and was well tolerated.
硬纤维瘤是接受直肠结肠切除术的家族性腺瘤性息肉病患者的第二大死亡原因。这些不发生转移但具有局部侵袭性的肿瘤,无论是药物治疗还是手术治疗都很困难。
一名20岁女性在因家族性腺瘤性息肉病接受结肠直肠切除术后6年前来就诊。发现了一个肠系膜硬纤维瘤。无法进行切除。在舒林酸治疗下肿瘤进展,出现了部分肠梗阻。给予患者他莫昔芬,每日20毫克,几天后肿瘤大小开始缩小,同时疼痛和压迫症状也有所减轻。该治疗耐受良好,持续了4.5年,与治疗前的大小相比,肿瘤体积缩小了20倍后保持不变。患者一直没有症状。
在这种危急的临床情况下,他莫昔芬产生了快速且持久的效果,并且耐受性良好。